Liver Transplantation Following Yttrium-90 Radioembolization: 15-year Experience in 207-Patient Cohort

Medicine and Dentistry

• Patient 100%
• Liver Transplantation 55%
• Yttrium 90 40%
• Recurrence Free Survival 25%
• Overall Survival 20%
• Hepatocellular Carcinoma 20%
• Diseases 10%
• Recurrent Disease 10%
• Radioembolization 10%
• Enalapril Maleate 10%
• Tumor Necrosis 10%
• Mortality 10%
• Inpatient 10%
• Organ 10%
• Log Rank Test 5%
• Survival Rate 5%
• Disease Exacerbation 5%
• Toxicity 5%
• Combination Therapy 5%
• Histopathology 5%
• Necrosis 5%
• Proportional Hazards Model 5%
• Neoadjuvant Therapy 5%
• Therapeutic Procedure 5%
• Liver 5%
• Experience 5%

INIS

• liver 60%
• patients 55%
• yttrium 90 40%
• hepatomas 20%
• diseases 15%
• necrosis 15%
• tumors 10%
• organs 10%
• mortality 10%
• radioembolization 10%
• data 5%
• therapy 5%
• toxicity 5%
• multivariate analysis 5%
• hazards 5%

Nursing and Health Professions

• Liver Transplantation 55%
• Yttrium 90 40%
• Recurrence Free Survival 25%
• Overall Survival 20%
• Time 15%
• Diseases 10%
• Recurrent Disease 10%
• Radioembolization 10%
• Mortality 10%
• Enalapril Maleate 10%
• Tumor Necrosis 10%
• Survival Rate 5%
• Vascular Guide Wire 5%
• Log Rank Test 5%
• Staging 5%
• Proportional Hazards Model 5%
• Combination Therapy 5%
• Toxicity 5%
• Disease Exacerbation 5%
• Neoadjuvant Therapy 5%
• Explant 5%
• Necrosis 5%